ETFs Cerus Corporation

CERS

US1570851014

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 16:00:00 2026-07-06 EDT			5-day change	1st Jan Change
3.280 ^USD	+3.80%		+9.70%	+59.22%

06-21	Cerus Corporation(NasdaqGM:CERS) added to S&P Healthcare Equipment Select Industry Index	CI
06-08	Cerus Corporation Enters into Second Amended and Restated Credit, Security and Guaranty Agreements for Term Loan and Revolving Loan Credit Facilities	CI

Cerus Corporation is a biomedical products company. The Company is focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System, which is based on its proprietary technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Its INTERCEPT Blood System is intended for use with blood components and certain of their derivatives: platelets, plasma, red blood cells and to produce INTERCEPT Fibrinogen Complex (IFC), and pathogen reduced plasma, cryoprecipitate reduced. The INTERCEPT Blood System for Cryoprecipitation uses its plasma system to produce IFC for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. In addition, the INTERCEPT Blood System for Cryoprecipitation is used to produce pathogen reduced plasma, cryoprecipitate reduced.

Employees

268

Sector

Medical Equipment, Supplies & Distribution

More about the company